Global Animal Model Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Animal Model Market is presumed to reach the market size of nearly USD 47.62 Billion by 2032 from USD 25.15 Billion in 2023 with a CAGR of 7.35% under the study period 2024 - 2032.

Animals model are those animals on whom biological and pathological experiments are performed and tested. The animal models are used because human beings and animals share a common biological and physiological structure. Though, the animals have a shorter lifespan but high genotype resemblance. Animal models are used increasingly in the biomedical research which helps in the development of the new therapy methods for the treatment of the diseases. With the help of the animal models, a better understanding of the disease can be done and the efficacy of the drugs can also be achieved. The animal research has a very important role in healthcare and medicinal science over the past century, in order to aid the understanding of the various disease.

Market Dynamics

Rising application of animal species in order to develop various novel therapy is likely to raise the growth of the animal model market. Moreover, the growing need to develop the more novel drugs in order to meet the huge unmet demand is estimated to the raise the growth. Growing various genetic disorders across the globe and increasing research field is serving as driving factor for. Also, the growing demand for an animal model to carry out various studies of the disease and human physiology is another major factor driving the growth of the market. However, the high cost of the study and strict regulatory framework is likely to hamper the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of animal model.

Market Segmentation

The broad animal model market has been sub-grouped into species, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Species

Rats
Mice
Guinea Pig
Rabbits
Monkeys
Dogs
Cats

By Application

Physiology
Toxicology
Cancer Research
Neurological Research
Biomedical Research
Genetic Research
Xenotransplantation

By End-User

Pharmaceutical Companies
Research Institutes
Contract Research Organizations
Educational Institutes
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for animal model in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the animal model market include Charles River Laboratories, Envigo, GenOway S.A, Harlan Laboratories, Janvier Labs, SAGE Labs, Taconic Laboratories, Transgenic, Inc., and Transposagen Biopharmaceuticals. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11210064

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ANIMAL MODEL - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Species
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-User
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ANIMAL MODEL MARKET ANALYSIS BY SPECIES

6.1 Overview by Species
6.2 Historical and Forecast Data
6.3 Analysis by Species
6.4 Rats Historic and Forecast Sales by Regions
6.5 Mice Historic and Forecast Sales by Regions
6.6 Guinea Pig Historic and Forecast Sales by Regions
6.7 Rabbits Historic and Forecast Sales by Regions
6.8 Monkeys Historic and Forecast Sales by Regions
6.9 Dogs Historic and Forecast Sales by Regions
6.10. Cats Historic and Forecast Sales by Regions

7 . GLOBAL ANIMAL MODEL MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Physiology Historic and Forecast Sales by Regions
7.5 Toxicology Historic and Forecast Sales by Regions
7.6 Cancer Research Historic and Forecast Sales by Regions
7.7 Neurological Research Historic and Forecast Sales by Regions
7.8 Biomedical Research Historic and Forecast Sales by Regions
7.9 Genetic Research Historic and Forecast Sales by Regions
7.10. Xenotransplantation Historic and Forecast Sales by Regions

8 . GLOBAL ANIMAL MODEL MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-User
8.2 Historical and Forecast Data
8.3 Analysis by End-User
8.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
8.5 Research Institutes Historic and Forecast Sales by Regions
8.6 Contract Research Organizations Historic and Forecast Sales by Regions
8.7 Educational Institutes Historic and Forecast Sales by Regions

9 . GLOBAL ANIMAL MODEL MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ANIMAL MODEL COMPANIES

10.1. Animal Model Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF ANIMAL MODEL INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Charles River Laboratories
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Envigo
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. GenOway S.A
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Harlan Laboratories
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Janvier Labs
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. SAGE Labs
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Taconic Laboratories
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Transgenic Inc.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Transposagen Biopharmaceuticals.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies